183 related articles for article (PubMed ID: 30256836)
21. Modeling of treatment response to erythropoiesis-stimulating agents in older (age≥70years) and younger (age<70years) patients with cancer and anemia: findings from the Anemia Cancer Treatment study.
Abraham I; MacDonald K; Tharmarajah S; Bokemeyer C; Ludwig H; Soubeyran P; Battistel V; Aapro M
J Geriatr Oncol; 2013 Apr; 4(2):196-201. PubMed ID: 24071545
[TBL] [Abstract][Full Text] [Related]
22. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
Servilla KS; Singh AK; Hunt WC; Harford AM; Miskulin D; Meyer KB; Bedrick EJ; Rohrscheib MR; Tzamaloukas AH; Johnson HK; Zager PG
Am J Kidney Dis; 2009 Sep; 54(3):498-510. PubMed ID: 19628315
[TBL] [Abstract][Full Text] [Related]
23. Association of a change in erythropoiesis-stimulating agent dose during hospitalization and subsequent hemoglobin levels and transfusions in hemodialysis patients.
Wong BC; Ravani P; Manns BJ; Lewin A; Zhang X; Chin R; Hemmelgarn BR; Tonelli M; Oliver MJ; Quinn RR
Am J Kidney Dis; 2013 Nov; 62(5):947-52. PubMed ID: 23856380
[TBL] [Abstract][Full Text] [Related]
24. Relationship between anaemia management at haemodialysis initiation and patient prognosis.
Kataoka H; Tsuchiya K; Naganuma T; Okazaki M; Komatsu M; Kimura T; Shiohira S; Kawaguchi H; Nitta K
Nephrology (Carlton); 2015 Dec; 20 Suppl 4():14-21. PubMed ID: 26456159
[TBL] [Abstract][Full Text] [Related]
25. Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients.
Lee YT; Tu CW; Kam KH; Ma TL; Kuo CH; Lee MY; Hsiao CY; Chan MWY; Hung PH
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142295
[TBL] [Abstract][Full Text] [Related]
26. Resistance to Erythropoiesis-Stimulating Agents in Pre-Dialysis and Post-Dialysis Mortality in Japanese Incident Hemodialysis Patients.
Hayashi T; Joki N; Tanaka Y; Iwasaki M; Kubo S; Matsukane A; Takahashi Y; Imamura Y; Hirahata K; Hase H
Blood Purif; 2019; 47 Suppl 2(Suppl 1):31-37. PubMed ID: 30943479
[TBL] [Abstract][Full Text] [Related]
27. Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease.
Wish JB; Nassar GM; Schulman K; del Aguila M; Provenzano R
Clin Nephrol; 2008 Apr; 69(4):251-9. PubMed ID: 18397699
[TBL] [Abstract][Full Text] [Related]
28. An economic evaluation of erythropoiesis-stimulating agents in CKD.
Clement FM; Klarenbach S; Tonelli M; Wiebe N; Hemmelgarn B; Manns BJ
Am J Kidney Dis; 2010 Dec; 56(6):1050-61. PubMed ID: 20932621
[TBL] [Abstract][Full Text] [Related]
29. Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time.
Robinson BM; Joffe MM; Berns JS; Pisoni RL; Port FK; Feldman HI
Kidney Int; 2005 Nov; 68(5):2323-30. PubMed ID: 16221236
[TBL] [Abstract][Full Text] [Related]
30. [Opatija study: observation of hemodialysis patients and titration of CERA dose just switched from another erythropoiesis stimulating agent].
Jelić I; Lovcić V; Kurtović I; Josipović M; Havranek Z; Kostić L; Racki S
Acta Med Croatica; 2012 Jul; 66(3):157-64. PubMed ID: 23441529
[TBL] [Abstract][Full Text] [Related]
31. High target hemoglobin with erythropoiesis-stimulating agents has advantages in the renal function of non-dialysis chronic kidney disease patients.
Tsubakihara Y; Gejyo F; Nishi S; Iino Y; Watanabe Y; Suzuki M; Saito A; Akiba T; Hirakata H; Akizawa T
Ther Apher Dial; 2012 Dec; 16(6):529-40. PubMed ID: 23190512
[TBL] [Abstract][Full Text] [Related]
32. Adherence to guidelines for use of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia: results of a retrospective study of an electronic medical-records database in the United States, 2002-2006.
Luo W; Nordstrom BL; Fraeman K; Nordyke R; Ranganathan G; Linz HE; Winterkorn A; Stokes M; Ross SD; Knopf K
Clin Ther; 2008 Dec; 30(12):2423-35. PubMed ID: 19167601
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysis.
Haag-Weber M; Vetter A; Thyroff-Friesinger U;
Clin Nephrol; 2009 Nov; 72(5):380-90. PubMed ID: 19863881
[TBL] [Abstract][Full Text] [Related]
34. Mortality and cardiovascular morbidity associated with haemoglobin levels: a pooled analysis of randomised controlled trials.
Locatelli F; de Francisco A; Deray G; Fliser D; Armstrong G; Dougherty FC; Ehrhard P
Nephron Clin Pract; 2014; 128(3-4):323-32. PubMed ID: 25503585
[TBL] [Abstract][Full Text] [Related]
35. Simplifying anemia management in hemodialysis patients: ESAs administered at longer dosing intervals can enhance opportunities to provide patient-focused care.
Schiller B; Besarab A
Curr Med Res Opin; 2011 Aug; 27(8):1539-50. PubMed ID: 21682552
[TBL] [Abstract][Full Text] [Related]
36. [Intravenous iron during predialysis period improves anemia management and cardiovascular parameters in incident hemodialysis patients].
Rottembourg J; Sonigo Y; Dansaert A; Diaconita M; Guerin A
Nephrol Ther; 2013 Dec; 9(7):486-93. PubMed ID: 24113201
[TBL] [Abstract][Full Text] [Related]
37. Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients.
Luo J; Jensen DE; Maroni BJ; Brunelli SM
Am J Kidney Dis; 2016 Nov; 68(5):763-771. PubMed ID: 27528373
[TBL] [Abstract][Full Text] [Related]
38. Utilization of darbepoetin alfa in relation to cancer patients' hemoglobin levels.
Hess G; Hill J; Clough J; Hulnick S; Nordyke RJ
Curr Med Res Opin; 2008 Mar; 24(3):815-9. PubMed ID: 18257979
[TBL] [Abstract][Full Text] [Related]
39. Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease.
Kim SM; Kim KM; Kwon SK; Kim HY
J Korean Med Sci; 2016 Jan; 31(1):55-60. PubMed ID: 26770038
[TBL] [Abstract][Full Text] [Related]
40. Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study.
Ingrasciotta Y; Giorgianni F; Marcianò I; Bolcato J; Pirolo R; Chinellato A; Ientile V; Santoro D; Genazzani AA; Alibrandi A; Fontana A; Caputi AP; Trifirò G
PLoS One; 2016; 11(5):e0155805. PubMed ID: 27187174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
